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Background: Transfusion with red blood cells (RBC) may be needed during hip revision surgery but the
appropriate haemoglobin concentration (Hb) threshold for transfusion has not been well established. We
hypothesized that a higher transfusion threshold would improve ambulation after hip revision surgery.
Methods: The trial was registered at Clinicaltrials.gov (NCT00906295). Sixty-six patients aged 18 years or older under-
going hip revision surgery were randomized to receive RBC at a Hb threshold of either 7.3 g/dL (restrictive group) or
8.9 g/dL (liberal group). Postoperative ambulation was assessed using Timed Up and Go-test (TUG) and ability to walk was
also assessed daily by a physiotherapist blinded to the allocation.
Results: Fifty-three patients were able to perform the TUG and included in the analysis. The TUG could be completed
in a median of 36 sec vs. 30 sec in the restrictive group and the liberal group, respectively (P = 0.02). The mean
difference in TUG was 14.5 sec (95% CI 2.8-26.2 sec). No difference was found in the day patients could perform TUG or
walk 10 meters. The Hb at the day of testing was 10.2 g/dL in the restrictive group and 9.9 g/dL in the liberal group.
Only 26 patients received RBC.
Conclusions: A Hb transfusion threshold of 8.9 g/dL was associated with a statistically significantly faster TUG after hip
revision surgery compared to a threshold of 7.3 g/dL but the clinical importance is questionable and the groups did
not differ in Hb at the time of testing.
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Orthopaedic surgery may be associated with significant
blood loss and transfusion with allogeneic red blood
cells (RBC) may be needed. Postoperative anaemia is
suspected to impair mobilization but the appropriate
haemoglobin concentration (Hb) threshold for transfu-
sion of RBC has not been well established. A relatively
high transfusion threshold may enhance postoperative
ambulation but potential side effects, immunologic as
well as non-immunologic, are reasons not to administer
allogeneic RBC liberally [1,2]. Increased morbidity and
mortality has been found in a recent analysis including
more than 10,000 surgical patients who received RBC
transfusion [3]. In contrast, no significant association* Correspondence: Kamillanielsen.kn@gmail.com
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unless otherwise stated.has been found between RBC transfusion and 30- or
90-day mortality in a large study [4]. A Cochrane review
on RBC transfusion thresholds identified 19 randomized
trials including a total of 6,264 patients. It suggested that
hospital mortality was 23% lower in patients in the re-
strictive compared to the liberal transfusion strategy
(RR0.77, 95% CI 0.62 to 0.95) and concluded that a re-
strictive transfusion threshold is safe in patients with-
out serious cardiac disease [5].
The American Society of Anesthesiologists recommends
transfusion of RBC to patients without cardiac disease at a
haemoglobin concentration of 6 g/dL [6]. Often patients
are not transfused according to these guidelines [4,7-9].
This could be due to concerns about early recovery since
anaemia in the immediately postoperative period could
impede mobilization and prolong hospital stay [10-12]. In
a study of young healthy volunteers increased level of
fatigue was reported during progressive isovolaemicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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data are not easily transferred to the often older and
frailer patients undergoing major joint surgery. No dif-
ference in mortality or the ability to walk at the 60-day
follow-up was found in a recent large randomized trial
in an elderly population with cardiovascular risk factors or
cardiac disease [14]. The aim of this study was to compare
the influence of two transfusion strategies on ambulation
in patients undergoing major joint surgery.
We hypothesized that a higher transfusion threshold
would improve ambulation after hip revision surgery.
Methods
The Committees on Biomedical Research Ethics of
the Capital Region of Denmark and the Danish Data
Protecting Agency approved the trial that was registered
at Clinicaltrials.gov (NCT00906295). Written informed
consent was obtained before surgery from all patients.
Patients were eligible if they were at least 18 years of age
and scheduled for elective hip revision surgery. Exclusion
criteria were disseminated cancer or cardiac disease
with functional impairment (NYHA class II or above).
Recruitment took place in the ward the day before surgery
or at the preanaesthetic assessment prior to surgery. The
randomization was done preoperatively after informed
consent was obtained. A dedicated computer program
(Idefix) was used after entering patients’ baseline data.
Only one investigator had access to the program. In-
vestigators at the other hospital had to call this investi-
gator to randomize. The allocation was written on a
form which was kept in the investigator’s office and the
allocation could only be accessed by the investigator in
charge of administrating red blood cells. The patients
were randomized to a restrictive strategy receiving
transfusion of RBC at a Hb of 7.3 g/dL (4.5 mmol/L) or
a liberal strategy receiving transfusion of RBC at a Hb of
8.9 g/dL (5.5 mmol/L). The target level of haemoglobin in
the restrictive group was 7.3 to 8.9 g/dL and above 8.9 g/dL
in the liberal group. The Danish National Board of Health
recommends transfusion of allogeneic RBC at a Hb of
7.3 g/dL, in patients free of cardiac disease [15]. The lowest
transfusion threshold was therefore set at 7.3 g/dL. The
transfusion threshold of the liberal group was set at 8.9 g/dL
since a higher level was likewise considered unethical.
During surgery, monitoring included pulse oximetry,
ECG, blood pressure (BP) measurement, and urinary
output. Patients were warmed by forced-air patient
warming system and core temperature was monitored.
General anaesthesia was administered using propofol
or sevoflurane with remifentanil or fentanyl. Spinal an-
aesthesia was used if requested by the patient and ac-
cepted by the attending anaesthesiologist. Tinzaparin
3,500 IE was given subcutaneously daily as thrombo-
prophylaxis from the evening before surgery and untildischarge from hospital. Two grams of tranexamic acid
were administered intravenously after surgical incision
to minimize blood loss. No blood salvage techniques were
used and no optimization of Hb before surgery was done.
Arterial blood gases were drawn to guide decisions about
transfusion and always at the end of surgery. We recorded
Hb, blood loss, urinary output, fluids administered, and
transfusions of blood products during surgery and in the
post anaesthesia care unit (PACU). If the patients had
returned to the ward before evening rounds an additional
Hb was measured on the day of surgery. Hb, pulse, BP,
fluids and RBC administered were noted daily from the
day following surgery and until testing of ambulation. Pain
was evaluated daily with a Visual Analogue Scale (VAS)
from 0–100 both at rest and while actively bending the
knee and hip to a maximum of 90 degrees. These mea-
surements were performed during weekdays.
Fluid therapy
Infusion of Ringers lactate or isotonic saline was started
before induction of anaesthesia and maintained during
surgery to replace urinary loss. Blood loss greater than
500 mL was replaced with the same volume of HES 130/0.4
(Voluven®, Fresenius Kabi Canada 45 Vogell Road, Suite
2010 Richmond Hill, Ontario L4B 3P6). Additional fluids
were administered if mean arterial pressure (MAP) de-
creased during or after surgery. If MAP decreased more
than 25% during surgery ephedrine, phenylephrine or
dopamine was administered. Fluid loss in the ward was
replaced orally. Additional Ringers lactate, isotonic sa-
line or HES 130/0.4 could be given if hypovolaemia or
severe dehydration was suspected.
Pain management
All patients had one gram of paracetamol administered
four times a day. The standard regimen included patient
controlled analgesia (PCA) using a bolus of 4 mg mor-
phine as needed and a continuous intravenous infusion
of morphine 1 mg per hour and continued in the ward
until standardized oral pain treatment with paraceta-
mol and morphine was initiated. Patients who had an
epidural catheter were given a continuous epidural in-
fusion of a mixture consisting of ropivacain1.25 mg
with morphine 50 μg per mL, 5 mL per hour. The epi-
dural catheter was kept for a maximum of three days
postoperatively. Local Infiltration Analgesia (LIA) could
be given as infiltration of a mixture of 100 mL ropivacain
2 mg/mL, ketorolac 15 mg, and epinephrine 0.25 mg
given at the end of surgery with additional boluses given
eight and 16 hours postoperatively via a catheter placed
within the joint capsule.
In the PACU pain treatment could be supplemented
with intravenous morphine, ketobemidone 5 mg or fentanyl
50 μg as needed.
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The rehabilitation program began the day after surgery.
The patients were consulted daily on weekdays for half
an hour by a physiotherapist. Patients were instructed in
range of motion as well as weight bearing and exercises
to improve vein flow. Isometric as well as active muscle
training were started and transferring and rising from
bed trained as well. Walking was initiated the first day
after surgery using a high-walker. Walking ability and
the need for appropriate walking-aids were evaluated
and from the second day this rehabilitation became
progressively more active.
Intervention
Transfusion of allogeneic RBC was administered accord-
ing to allocation but the attending orthopaedic surgeon
could decide to give additional transfusion of RBC as a
safety precaution. In that situation, the investigator had
to be notified and a reason for transfusing was documented.
Fresh frozen plasma was given along the seventh unit of
RBC or if laboratory tests indicated it.
Endpoints
The primary outcome measure was the Timed Up and
Go-test [16]. TUG was used to assess the time it takes a
patient to stand up, walk three meters, turn around,
walk back and sit down again. On the command “ready-
walk” the patient rises from a chair and walks to a line
on the floor. At least one foot has to touch the line. The
patient was encouraged to do the test as fast as possible.
No support from another person was allowed during
testing but verbal guidance could be given. The proced-
ure was timed by the physiotherapist and no practice
trial was done. TUG was performed on the day patients
were considered able to walk at least six meters and rise
from a chair.
Secondary outcome measures were the day the pa-
tients could perform TUG, the day a 10 meter walking
distance was reached, and length of hospital stay. It was
recorded if patients were only allowed partial weight
bearing on the operated leg, had an epidural or used
walking aids during TUG.
The patient’s medical files were scrutinized to assess
postoperative complications within 30 days after surgery.
The allocation and Hb during the testing period were
concealed from the patients but the investigator, the staff
in the operating room, and at the staff at the ward could
not be blinded. The physiotherapist testing the patient
was blinded. The operating room staff, the PACU nurse
and the ward nurses were informed not to reveal the al-
location or Hb. Stickers in the patient’s medical file in-
formed the staff that the patient participated in the trial
and therefore should not be informed about Hb. Patients
were seen every weekday by another physiotherapistthan the one responsible for ambulation. Two separate
case report forms were used, one set for the investigator
and another for the physiotherapist testing the patient.
The case report forms were kept separately from the pa-
tients file. The analyses of the primary and secondary
endpoints were done blindly by concealing the allocation
during the statistical analysis.
Statistics
Patient characteristics and perioperative variables were
reported using median and interquartile range. Mann-
Whitney’s test was used to compare TUG and Chi
square test used to compare day for TUG and day for
10 meter walking distance. A two-sided probability
value of less than 0.05 was considered significant.
A difference in TUG of 15 seconds was considered
clinically relevant. A former study found a SD for TUG
of 17.6 seconds in elderly patients undergoing total hip
replacement [17]. A sample of 52 patients was considered
necessary to detect a difference of 15 seconds with a power
of 85% at the 5% significance level. Statistical analyses were
performed with SAS 9.1 for Windows.
Results
Sixty-seven patients were enrolled between June 22,
2009 and May 13, 2011 (Figure 1). One patient had
surgery cancelled before randomization. A total of 66
patients were randomized. Fifty-five patients were in-
cluded at Rigshospitalet and twelve patients at Bispebjerg
hospital. Demographic characteristics were similar between
the groups (Table 1).
Perioperative blood loss, fluid therapy, and Hb values
are displayed in Table 2 and Figure 2. The median
perioperative blood loss was 575 mL and 900 mL in
the restrictive group and the liberal group, respectively
(P = 0.10). A total of eleven patients in the restrictive
group and sixteen in the liberal group received trans-
fusion of RBC. Six patients in the restrictive group re-
ceived eleven units of RBC not according to protocol.
In the liberal group three patients received five units
of RBC not according to protocol (P = 0.28). One patient
in each group had gastric bleeding necessitating RBC
transfusion. Other indications for giving transfusions not
according to allocation included fatigue, dizziness, pallor,
nausea, dyspnoea, and atrial fibrillation. The distribution
of postoperative complications was similar as to the
number of patients who experienced complications.
Thirty-two complications were registered in the restrictive
group and 54 in the liberal group (0.01) (Table 3).
Fifty-three patients were able to perform TUG. The
median time for TUG was 36 (5-95% range: 16–57)
and 30 seconds (5-95% range: 23–87) in the restrictive
and liberal group, respectively (P = 0.02). TUG was per-
formed after a median of 2.0 days (restrictive group) and
Figure 1 Patient flow. Patient enrolment, randomization and treatment flow.
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groups were able to walk 10 meters at a median of two
days after surgery (P = 0.81) (Table 4). Median length of
hospital stay was eight days in both groups.
Twenty-four of the 66 randomized patients reached
the allocated level of Hb at the time of testing; eight pa-
tients in the restrictive group and 16 in the liberal group.
No difference in the time to perform TUG was found in
this subgroup.
All patients were alive at the 30-day follow-up.
Discussion
In patients undergoing hip revision surgery, a Hb transfu-
sion threshold of 8.9 g/dL was associated with a statistically
significant faster postoperative TUG than a threshold of
7.3 g/dL. However, the difference between the median
values was only six seconds, and there was no difference
regarding how soon after surgery the patients could per-
form TUG or walk 10 meters. Not surprising, more pa-
tients received RBC transfusion in the liberal group andmore patients in the restrictive group were transfused
not according to protocol.
Several limitations in this study have to be discussed.
Firstly, Hb decreased by approximately 25% after surgery
in both groups and the transfusion threshold was never
reached in a considerable number of patients, which
minimized the potential difference between the groups.
Secondly, the median Hb was 10.2 g/dL and 9.9 g/dL in
the in the restrictive and liberal group, respectively, on
the day of TUG testing. The small difference in TUG is
therefore not likely related to a difference in Hb and the
clinical importance is highly questionable.
The detected difference in TUG was much smaller than
the 15 seconds we considered clinically relevant. The sam-
ple size calculation was based on data that seemed to be
of limited relevance for our specific patient group but that
was not known when the trial was planned.
The minor difference in Hb between the two groups
was related to the fact that intraoperative blood loss was
quite limited. The perioperative blood loss tended to be





Age, years 68 (43–86) 72 (53–89)
Men/women, no. (% men) 16/17 (48) 20/13 (61)
Body mass index, kg/m2 27 (20–39) 26 (20–34)
American Society of Anesthesiologists physical status score, no. (%)
1 5 (15) 6 (18)
2 26 (79) 22 (67)
3 2 (6) 5 (15)
Comorbidities, no. (%)
Current smoker 4 (12) 5 (15)
Diabetes 6 (18) 4 (12)
Hypertension 18 (55) 19 (57)
Other cardiovascular disease 5 (15) 7 (21)
Lung disease 2 (6) 3 (9)
Neurologic disease 1 (3) 2 (6)
Kidney disease 1 (3) 0
Other disease 8 (24) 8 (24)
Preoperative haemoglobin concentration, g/dL 13.4 (10.2-15.0) 13.8 (10.5-16.3)
Patient characteristics of patients undergoing hip revision surgery and randomized to a transfusion threshold of red blood cells of a haemoglobin concentration
of 7.3 or 8.9 g/dL, restrictive group and liberal group, respectively.
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significant. Nonetheless, the greater blood loss in the
liberal group mades it difficult to achieve a difference
in Hb between the groups. Likewise, more fluid was
administered in the liberal group. Thirdly, we included
patients scheduled for revision surgery of the hip, re-
gardless of the indication for surgery, making our co-
hort somewhat heterogeneous in terms of surgical
procedure and to what extent patients could be mobi-
lized (Table 2). Finally, the type of anaesthesia was not
strictly standardized and several different regimens of
postoperative pain relief were employed. In particular,
lumbar epidural analgesia may cause motor paralysis of
the lower extremities which may influence ambulation.
Pain was not evaluated in detail at the time of testing
and this may affect the TUG-score but pain intensity
was generally low and not different between groups.
The different types of walking aids used could also
affect the time it takes to do perform the TUG. Other
limitations include that the TUG was performed with-
out a practice trial as often recommended and that the
TUG-testing took place on weekdays only. The latter
was due to the limited availability of physiotherapy
during weekends, which potentially could obscure the
effect of the intervention. Given these limitations, it is
difficult to say whether a liberal transfusion strategy is
indeed advantageous for mobilization after major hipsurgery but the findings in our trial do not firmly support
a liberal transfusion strategy.
The Danish National Board of Health recommends
transfusion of allogeneic RBC at a Hb of 7.3 g/dL, in
patients free of cardiac disease [15]. The lowest transfusion
threshold was therefore set at 7.3 g/dL. Compared to guide-
lines issued by The American Society of Anaesthesiologists
it can be argued that the lower limit was too high. The
transfusion threshold in Denmark is, however, at that
level and a lower limit than the one issued by the na-
tional authorities was considered unethical.
The total number of complications were larger in the
liberal group and more patients experienced complications
in this group, although not significantly more. The trial
was not designed to investigate complications of RBC
transfusion. Still, some pulmonary complications may be
related to TRALI, a known complication to transfusion.
This would support a restrictive strategy of transfusion.
Our trial did not address whether a higher transfusion
threshold could have any long-term effect since patients
were tested within the third day of surgery.
A higher level of haemoglobin could increase the
amount of oxygen delivered to the tissues. Accordingly,
symptoms of anaemia, such as impaired mobilization,
should be alleviated. Still, the trials conducted so far
have shown contradicting results [10,11,18-31], and
the majority is of observational design [10,11,18-24]
Table 2 Perioperative variables, median with (5-95% range), or number with proportion
Restrictive group (n = 33) Liberal group (n = 33) P-value
Surgery
Type of surgery, no. (%)
Total revision 13 (43) 15 (45.5) 0.05
Acetabular component revision 9 (30) 15 (45.5)
Femoral component revision 6 (20) 2 (6)
Other 2 (7) 1 (3)
Type of anesthesia, no. (%)
General anaesthesia 26 (87) 31 (94) 0.41
Spinal anaesthesia 4 (13) 2 (6)
Pain management, no. (%)
Femoral nerve block 2 (7) 1 (3) 0.60
Local infiltration analgesia with catheter 2 (7) 1 (3) 0.60
Local infiltration analgesia without catheter 8 (27) 10 (30) 0.79
Epidural as postoperative pain management 11 (33) 17 (52) 0.31
Blood loss during surgery, mL 575 (150–2300) 900 (200–2900) 0.10
Urinary output during surgery, mL 340 (76–975) 300 (65–1000) 0.84
Fluids given during surgery, mL1
Red Blood Cells 0 (0–490) 0 (0–980) 0.05
Crystalloids 1500 (500–3500) 1500 (300–3100) 0.64
Colloids 500 (0–1500) 750 (0–2000) 0.11
Last Hb measured during surgery, g/dL 9.9 (6.5-12.8) 10.4 (8.3-12.9) 0.31
Post Anaesthesia Care Unit (PACU)1
Blood loss in drain if used, mL 150 (0–700) 150 (0–500) 0.73
Urinary output during stay at PACU, mL 121 (49–190) 260 (45–1000) 0.70
Transfusions of red blood cells in PACU, mL 0 (0–245) 0 (0–245) 0.43
Crystalloids given in PACU, mL 700 (200–1200) 1000 (200–2400) 0.03
Colloids given in PACU, mL 0 (0–500) 0 (0–500) 0.93
Haemoglobin concentration at discharge from PACU, g/dL 9.9 (7.9-12.0) 10.2 (8.9-14.4) 0.16
Postoperative period
Crystalloids given, mL 0 (0–4000) 500 (0–4000) 0.66
Colloids given, mL 0 (0–500) 0 (0–1500) 0.25
Total perioperative transfusions of red blood cells, mL 0 (0–1470) 245 (0–1225) 0.22
Total number of patients transfused, no. (%) 11 (37) 16 (48) 0.32
Mean where indicated.
Type of surgery, anesthesia, and perioperative fluid and pain management of patients undergoing hip revision surgery and randomized to receive transfusion of
red blood cells at a haemoglobin concentration of 7.3 or 8.9 g/dL, restrictive group and liberal group, respectively.
1One patient in the liberal group was transfused 1,100 mL of fresh frozen plasma (FFP) during sugery and one patient in the restrictive group was transfused
275 mL of FFP in the Post Anasthesia Care Unit. No further transfusions of FFP was given nor did any patients receive transfusion of platelets during the trial.
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trial indicate that perioperative blood loss in hip revi-
sion surgery infrequently requires RBC transfusion,
probably as a result of improved surgical techniques
and the use of fibrinolytic medication. Previous trials
have also experienced challenges similar to the ones
encountered in ours. Several lessons can be learnedfrom our study and should be taken into consideration
by investigators who want to study transfusion thresh-
olds and ambulation. Firstly, the type of surgery should
be considered thoroughly. It should be an operation
with the potential of early postoperative ambulation
as well as a substantial loss of blood. Secondly, the
risk of protocol violation must be minimized by a strict
Figure 2 Haemoglobin concentration. Median haemoglobin concentration in patients undergoing hip revision surgery and randomized to a
transfusion threshold of red blood cells of a haemoglobin concentration of 7.3 or 8.9 g/dL, restrictive group and liberal group, respectively. Plotted from
before surgery until TUG was performed or patients were discharged from hospital. The number of patients is shown with digits above the graphs.
Table 3 Postoperative complications
Restrictive group (n = 30) Liberal group (n = 33) P value
Gastrointestinal complications 12 13
Pneumonia 0 4
Other pulmonary 2 3






Deep vein thrombosis 0 1
Surgical site infection 0 1
Fall at the ward or at home 3 2
Others 3 16
Total number of patients experiencing postoperative complications 19 22 0.61
Patients experiencing one postoperative complication 9 6
Patients experiencing two postoperative complications 5 6
Patients experiencing three postoperative complications 4 4
Patients experiencing four postoperative complications 1 3
Patients experiencing five postoperative complications 0 3
Total number of postoperative complications 34 57 0.01
Postoperative complications 30 days after surgery in patients undergoing hip revision surgery and randomized to receive transfusion of red blood cells at a
haemoglobin concentration of 7.3 or 8.9 g/dL, restrictive group and liberal group, respectively.
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Table 4 Functional outcomes and pain scores, median with (5-95% range), or number with proportion
Restrictive group Liberal group P value
Time for Timed Up and Go test, seconds 36 (16–57) (n = 25) 30 (23–87) (n = 28) 0.02
Postoperative day patients could perform TUG




≥ 5 7 6
Postoperative day patients were able to walk 10 meters
1 11 12 0.93
2 11 10
≥3 4 7
Patients TUG tested with epidural catheter, no. (%) 2 (8) (n = 25) 4 (14) (n = 28) 0.67
Pain score on the day of testing
VAS-score at rest* 0.5 (0–29) (n = 24) 0 (0–48) (n = 25) 0.86
VAS-score at activity† 20.5 (0–67) (n = 24) 22 (0–75) (n = 25) 0.79
Hb at the day of test, g/dL 10.2 (8.1-11.8) (n = 23) 9.9 (8.3-12.5) (n = 28) 0.87
Length of hospital stay after surgery, days 8 (4–44) (n = 33) 8 (4–38) (n = 33) 0.71
Allowed only partial weight bearing, no. (%) 12 (48) 14 (50) 1.00
Type of walking aid, no. (%)
Crutches 11 (44) 11 (39) 0.11
Zimmer frame 1 (4) 3 (11)
Walking frame 6 (24) 3 (11)
Highwalker 7 (28) 11 (39)
Postoperative functional outcome measures and pain scores for patients undergoing hip revision surgery and randomized to a transfusion threshold of red blood
cells of a haemoglobin concentration of 7.3 or 8.9 g/dL, restrictive group and liberal group, respectively.
*Visual Analogue Scale score assessed from 0 to 100 during rest.
†Visual Analogue Scale score assessed from 0 to 100 while actively flexing the knee to a maximum.
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over the postoperative period where numerous medical
doctors will be involved patient care. Perioperative
blood loss is impossible to predict and a large propor-
tion of patients will only have a minor blood loss and
no need for transfusion of RBC. Another major con-
cern in transfusion medicine is the need for a “golden
standard” in measuring ambulation and walking ability.
Different studies uses different outcome measures making
comparison between trials problematic.
Our study may be considered a feasibility study that
illustrates the significant challenges in studying transfusion
thresholds, especially related to compliance with the proto-
col and as such, it can hopefully provide the basis for new
prospective studies in this field.
Conclusions
In conclusion, a Hb transfusion threshold of 8.9 g/dL was
associated with a statistically significantly faster TUG after
hip revision surgery than a threshold of 7.3 g/dL but theclinical importance is questionable and the groups did not
differ in Hb at the time of testing.
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